A Phase Iii, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib (Gs-1101) in Combination with Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas (Inhl).
Journal of Clinical Oncology（2013）
关键词
Ibrutinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要